Advances in molecular biology have identified ARVC/D as a genetic disorder of cardiac desmosomes, offering potential for early genetic screening and improved clinical management, though limited by incomplete penetrance and complex genetics.
No takes yet. Share an insight, caveat, or question.
May inform cautious family screening in ARVC/D; leaves open prospective validation of penetrance-guided management.
Corrado et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: